Defence Therapeutics Inc. (FRA:DTC)
0.502
-0.040 (-7.38%)
At close: Dec 4, 2025
31.76% (1Y)
| Market Cap | 31.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.21M |
| Shares Out | n/a |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 5,658 |
| Open | 0.498 |
| Previous Close | 0.542 |
| Day's Range | 0.498 - 0.502 |
| 52-Week Range | 0.317 - 1.170 |
| Beta | n/a |
| RSI | 50.62 |
| Earnings Date | Nov 19, 2025 |